{"SPADE_UN_20436": {"Sequence Information": {"Peptide Name": "Jellein-1 [I4L]", "Sequence": "PFKLSLHL", "Sequence Length": 8, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-Mammalian Cell", "Antibiofilm"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "O18330", "uniprotUrl": "http://www.uniprot.org/uniprot/O18330", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "The effect of halogenation on the antimicrobial activity, antibiofilm activity, cytotoxicity and proteolytic stability of the antimicrobial peptide Jelleine-I.", "Pubmed ID": "30500360", "Reference": "Peptides. 2018;112:56-66", "Author": "Jia F, Zhang Y, Wang J, Peng J, Zhao P, Zhang L, Yao H, Ni J, Wang K ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30500360"}, {"Title": "The in vitro, in vivo antifungal activity and the action mode of Jelleine-I against Candida species.", "Pubmed ID": "29101485", "Reference": "Amino Acids. 2018;50:229-239", "Author": "Jia F, Wang J, Peng J, Zhao P, Kong Z, Wang K , Yan W, Wang R", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29101485"}, {"Title": "An optimized analog of antimicrobial peptide Jelleine-1 shows enhanced antimicrobial activity against multidrug resistant P. aeruginosa and negligible toxicity in vitro and in vivo.", "Pubmed ID": "33878564", "Reference": "Eur J Med Chem. 2021;219:113433", "Author": "Zhou J, Zhang L, He Y, Liu K, Zhang F, Zhang H, Lu Y, Yang C, Wang Z, Fareed MS, Liang X, Yan W, Wang K ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33878564"}], "Mass": 954.17, "PI": 9.18, "Net Charge": 2, "Hydrophobicity": 0.59, "Frequent Amino Acids": "LFH", "Absent Amino Acids": "ACDEGIMNOQRTUVWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 4, "Polar Residues": 4, "Positive Residues": 2, "Negative Residues": 0, "SPADE ID": "SPADE_UN_20436", "Similar Sequences": [{"SPADE_ID": "SPADE_N_06349", "Similarity": 1.0, "Sequence": "KKCKFFCKVKKKIKSIGFQIPIVSIPFK"}, {"SPADE_ID": "SPADE_N_07770", "Similarity": 1.0, "Sequence": "TPFKLSLHL"}, {"SPADE_ID": "SPADE_N_07771", "Similarity": 1.0, "Sequence": "EPFKLSLHL"}], "Hemolytic Activity": "Mouse erythrocytes:0% Hemolysis=256 µM,Mouse fibroblasts NIH 3T3:10% Killing=256 µM,Human erythrocytes:<5% Hemolysis=<256 µM,Mouse fibroblasts NIH 3T3:<15% Killing=256 µM", "Target Organism": "Staphylococcus aureus ATCC 29213(MIC=128µM),Staphylococcus aureus ATCC 29213(MBC=128µM),Bacillus subtilis ATCC 23857(MIC=32µM),Bacillus subtilis ATCC 23857(MBC=64µM),Staphylococcus epidermidis ATCC 12228(MIC=64µM),Staphylococcus epidermidis ATCC 12228(MBC=64µM),Escherichia coli ATCC 25922(MIC=32µM),Escherichia coli ATCC 25922(MBC=64µM),Pseudomonas aeruginosa ATCC 27853(MIC=32µM),Pseudomonas aeruginosa ATCC 27853(MBC=256µM),Klebsiella pneumoniae ATCC 700603(MIC=64µM),Klebsiella pneumoniae ATCC 700603(MBC=128µM),Cronobacter sakazakii ATCC 29544(MIC=64µM),Cronobacter sakazakii ATCC 29544(MBC=128µM),Escherichia coli ATCC 43827(MIC=32µM),Escherichia coli ATCC 43827(MIC=64µM),Candida glabrata ATCC 2001(MIC=30µg/ml),Candida glabrata ATCC 2001(MFC=61µg/ml),Candida albicans ATCC 14053(MIC=61µg/ml),Candida albicans ATCC 14053(MFC=61µg/ml),Candida tropicalis ATCC 750(MIC=15µg/ml),Candida tropicalis ATCC 750(MFC=30µg/ml),Candida krusei ATCC 6258(MIC=30µg/ml),Candida krusei ATCC 6258(MFC=30µg/ml),Candida parapsilosis ATCC 22019(MIC=61µg/ml),Candida parapsilosis ATCC 22019(MFC=122µg/ml),Escherichia coli ATCC 25922(MIC=32µM),Pseudomonas aeruginosa ATCC 27853(MIC=32µM),Staphylococcus aureus ATCC 29213(MIC=128µM),Bacillus subtilis ATCC 23857(MIC=32µM),Staphylococcus epidermidis ATCC 12228(MIC=64µM),Staphylococcus aureus MR(MIC=128µM),Escherichia coli ESBL (MIC=32µM),Pseudomonas aeruginosa(MIC=32µM),Human cervical carcinoma HeLa(10-20% Killing=256µM),Murine macrophage cells RAW 264.7(10-20% Killing=256µM)"}}}